Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (561-570 of 7,109) with videos related to

Pageof 711
Sort By:
Cancer Science|July 12, 2008
High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinomaTomonori Sasahira, Tadaaki Kirita, Naohide Oue, et al.
Cancer Science|July 12, 2008
TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signalingAtsuo Kurata, Ryohei Katayama, Toshiki Watanabe, et al.
Cancer Science|July 12, 2008
beta-catenin is strongly elevated in rat colonic epithelium following short-term intermittent treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and a high-fat dietRong Wang, W Mohaiza Dashwood, Christiane V Löhr, et al.
Cancer Science|February 25, 2009
Cancer epigenomics: implications of DNA methylation in personalized cancer therapyMinoru Toyota, Hiromu Suzuki, Toshiharu Yamashita, et al.
Cancer Science|February 27, 2009
Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomasTetsuo Ushiku, Hiroshi Uozaki, Aya Shinozaki, et al.
Cancer Science|February 28, 2009
Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cellsMasayoshi Kobune, Rishu Takimoto, Kazuyuki Murase, et al.
Cancer Science|February 28, 2009
Efficient inhibition of SDF-1alpha-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonistsYuki Iwasaki, Hirofumi Akari, Tsutomu Murakami, et al.
Cancer Science|December 17, 2008
Safety and efficacy of rasburicase (SR29142) in a Japanese phase II studyKenichi Ishizawa, Michinori Ogura, Motohiro Hamaguchi, et al.
Cancer Science|December 17, 2008
Recent advances in the molecular pathology of soft tissue sarcoma: implications for diagnosis, patient prognosis, and molecular target therapy in the futureYoshinao Oda, Masazumi Tsuneyoshi
Cancer Science|March 21, 2009
Therapeutic potential of proapoptotic molecule Noxa in the selective elimination of tumor cellsSaori Suzuki, Makoto Nakasato, Tsukasa Shibue, et al.
Pageof 711

Showing results (561-570 of 7,109) with videos related to

Sort By:
Pageof 711
Cancer Science|July 12, 2008
High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinomaTomonori Sasahira, Tadaaki Kirita, Naohide Oue, et al.
Cancer Science|July 12, 2008
TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signalingAtsuo Kurata, Ryohei Katayama, Toshiki Watanabe, et al.
Cancer Science|July 12, 2008
beta-catenin is strongly elevated in rat colonic epithelium following short-term intermittent treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and a high-fat dietRong Wang, W Mohaiza Dashwood, Christiane V Löhr, et al.
Cancer Science|February 25, 2009
Cancer epigenomics: implications of DNA methylation in personalized cancer therapyMinoru Toyota, Hiromu Suzuki, Toshiharu Yamashita, et al.
Cancer Science|February 27, 2009
Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomasTetsuo Ushiku, Hiroshi Uozaki, Aya Shinozaki, et al.
Cancer Science|February 28, 2009
Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cellsMasayoshi Kobune, Rishu Takimoto, Kazuyuki Murase, et al.
Cancer Science|February 28, 2009
Efficient inhibition of SDF-1alpha-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonistsYuki Iwasaki, Hirofumi Akari, Tsutomu Murakami, et al.
Cancer Science|December 17, 2008
Safety and efficacy of rasburicase (SR29142) in a Japanese phase II studyKenichi Ishizawa, Michinori Ogura, Motohiro Hamaguchi, et al.
Cancer Science|December 17, 2008
Recent advances in the molecular pathology of soft tissue sarcoma: implications for diagnosis, patient prognosis, and molecular target therapy in the futureYoshinao Oda, Masazumi Tsuneyoshi
Cancer Science|March 21, 2009
Therapeutic potential of proapoptotic molecule Noxa in the selective elimination of tumor cellsSaori Suzuki, Makoto Nakasato, Tsukasa Shibue, et al.
Pageof 711